A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary)
- Indications Migraine with aura
- Focus Therapeutic Use
- 16 Feb 2012 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
- 16 Feb 2012 Planned end date changed from 1 Sep 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 16 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.